| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 87031 |
1006711-90-5，DOTA-Mal |
82 |
kx |
2024-11-21 |
| 87032 |
DOTA-PAMAM DOTA-PAMAM树状大分子 |
115 |
zcy |
2024-11-21 |
| 87033 |
CAS:619300-53-7，金属离子螯合剂DOTA-NOC |
115 |
kx |
2024-11-21 |
| 87034 |
porphyrin-amido-benzyl-DOTA 卟啉-p-NH2-苄基-DOTA缀合物 |
114 |
zcy |
2024-11-21 |
| 87035 |
170908-81-3,DOTA-NHS ester,DOTA活性酯 |
83 |
kx |
2024-11-21 |
| 87036 |
DOTA-SP DOTA-substance P DOTA偶联神经肽类似物 |
103 |
zcy |
2024-11-21 |
| 87037 |
DOTA-3-酪氨酰基-奥曲肽 |
87 |
kx |
2024-11-21 |
| 87038 |
CAS号2389064-47-3 DOTA-tris(TBE)-amido-dPEG4-TFP ester |
154 |
zyl |
2024-11-21 |
| 87039 |
C13-R8的简单介绍 |
102 |
kx |
2024-11-21 |
| 87040 |
DOTA-GGGF-ITC 齐岳定制 |
113 |
zcy |
2024-11-21 |
| 87041 |
p-NH2-Bn-DOTA-四叔丁酯 |
115 |
zyl |
2024-11-21 |
| 87042 |
CAS号：213187-44-1 DOTA-BIM-23014:DOTA-Lanreotide |
114 |
zyl |
2024-11-21 |
| 87043 |
1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid-lanreotide 定制 |
89 |
zcy |
2024-11-21 |
| 87044 |
DOTA-cyclo(RGDfK) acetate |
86 |
zyl |
2024-11-21 |
| 87045 |
NHS-DOTA 齐岳供应 |
114 |
zcy |
2024-11-21 |
| 87046 |
叠氮-PEG-氨基（N3-PEG-NH2） |
175 |
WYQ |
2024-11-21 |
| 87047 |
CAS号：149819-85-2，Iron DOTA Sodium Salt |
93 |
zyl |
2024-11-21 |
| 87048 |
叠氮化的5,10,15,20四苯基卟啉（PPN3） |
146 |
WYQ |
2024-11-21 |
| 87049 |
金属螯合剂DOTA Acrylamide |
156 |
kx |
2024-11-21 |
| 87050 |
双(2-叠氮基乙基)3,3'-(丙烷-2,2-二基双(硫代二烷基))二丙酸酯（TK-N3） |
98 |
WYQ |
2024-11-21 |
| 87051 |
DOTA-PEG48-Cys-VS DOTA修饰的单分散PEG结合的巯基化双抗体 |
128 |
zcy |
2024-11-21 |
| 87052 |
炔基功能化的聚谷氨酸(PPLG) |
147 |
WYQ |
2024-11-21 |
| 87053 |
两亲性分子寡聚苯撑乙炔衍生物OPE-PEG-NH2 |
118 |
WYQ |
2024-11-21 |
| 87054 |
DOTA-ACA，DOTA-丙烯酰胺，DOTA-Acrylamide |
98 |
kx |
2024-11-21 |
| 87055 |
DOTA-(His)2-minigastrin 科研定制 |
88 |
zcy |
2024-11-21 |
| 87056 |
DOTA-(His)2-minigastrin 科研定制 |
94 |
zcy |
2024-11-21 |
| 87057 |
叠氮修饰的三嵌段聚合物PEG-b-P(BIEM-N3)-b-PtBA |
269 |
WYQ |
2024-11-21 |
| 87058 |
DOTA-(Tyr3)-Octreotate |
144 |
kx |
2024-11-21 |
| 87059 |
DOTA-PP-F11N DOTA-(dGlu) 齐岳供应 |
96 |
zcy |
2024-11-21 |
| 87060 |
DOTA-E[c(RGDfK)2],DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys) |
93 |
kx |
2024-11-21 |
| 87061 |
753421-63-5，DOTA-C4-NH2 |
94 |
kx |
2024-11-21 |
| 87062 |
Ga-DOTA-TOC acetate，CAS号：293295-70-2 |
125 |
zyl |
2024-11-21 |
| 87063 |
DOTA-D-Tat peptide stock solution (3 mM) 齐岳供应 |
101 |
zcy |
2024-11-21 |
| 87064 |
DOTA-Acrylamide,DOTA-DBCO,DOTA-MeTz |
98 |
kx |
2024-11-21 |
| 87065 |
DOTA-Knottin Peptide 齐岳定制 |
114 |
zcy |
2024-11-21 |
| 87066 |
DOTA-RGD,DOTA多肽衍生物 |
143 |
kx |
2024-11-21 |
| 87067 |
DOTA-Nal3-Octreotide DOTANOC DOTA-Nal3-奥曲肽 |
110 |
zcy |
2024-11-21 |
| 87068 |
DOTA-丙烯酰胺,DOTA Acrylamide |
103 |
kx |
2024-11-21 |
| 87069 |
DOTA Tris-(t-butyl ester) Ethylenediamino Monoamide |
102 |
zyl |
2024-11-21 |
| 87070 |
1262403-91-7,七肽DOTA-YLYEIAR,螯合物前体肽 |
97 |
kx |
2024-11-21 |
| 87071 |
DOTA-8-AOC-BBN (7-14)NH2 NOTA-共轭铃蟾肽衍生物 |
103 |
zcy |
2024-11-21 |
| 87072 |
多叠氮基聚乙二醇衍生物(PEGn(N3))m |
93 |
WYQ |
2024-11-21 |
| 87073 |
DOTA derivative，CAS号：153777-70-9 |
88 |
zyl |
2024-11-21 |
| 87074 |
多炔基聚乙二醇衍生物(PEGn(C≡CH))m |
132 |
WYQ |
2024-11-21 |
| 87075 |
173308-19-5,DOTA-(COOt-Bu)3-C2-NH2 |
85 |
kx |
2024-11-21 |
齐岳微信公众号
官方微信
库存查询